Spear and Griswald 9 reported the first case of a fall in blood pressure after the administration of dibenamine (N, N-dibenzyl-β-chloroethylamine) to a patient who proved at operation to have a ...

In view of the array of symptoms, the patient was referred for medical evaluation of a suspected pheochromocytoma, a neuroendocrine tumor of the adrenal gland. He underwent 24-hour blood pressure ...

Comprehensive reviews of the literature related to management and diagnosis of pheochromocytoma are available elsewhere.

The use of such drugs to block the effects of epinephrine will provide a more specific test in the diagnosis of pheochromocytoma. However, such agents as the benzodioxane derivatives can produce ...

A metaiodobenzylguanidine scan showed positive uptake within the mass, which supported a diagnosis of pheochromocytoma. The patient underwent a laparoscopic right suprarenal adrenalectomy after ...

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025.

Most tumors in the adrenal glands are benign (noncancerous) and don't often cause symptoms. However, if your tumor becomes ...

About one-third of pheochromocytoma cases are inherited or genetic. Genetic screening can provide critical information about the patient's chance of recovery. Comprehensive screening for family ...

The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma.

A pheochromocytoma is a tumor that produces adrenaline ... Usually, it presents with no apparent signs or symptoms, unless the adrenal glands are producing excessive hormones (such as cortisol and ...

Rahway, New Jersey Tuesday, January 28, 2025, 10:00 Hrs [IST] ...

Results from the trial will be presented at an upcoming medical meeting. “Pheochromocytoma and paraganglioma are rare tumors that form in and around the adrenal glands, and currently, there are no ...